Identification of an Immune-Related Risk Signature Correlates With Immunophenotype and Predicts Anti-PD-L1 Efficacy of Urothelial Cancer.
Li P, Hao S, Ye Y, Wei J, Tang Y, Tan L, Liao Z, Zhang M, Li J, Gui C, Xiao J, Huang Y, Chen X, Cao J, Luo J, Chen W.
Li P, et al. Among authors: chen w, chen x.
Front Cell Dev Biol. 2021 Mar 18;9:646982. doi: 10.3389/fcell.2021.646982. eCollection 2021.
Front Cell Dev Biol. 2021.
PMID: 33816497
Free PMC article.